insights_auto
Why is REGN34 up ४.१८%?
Dive Deeperchevron_right
REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$ ६७.७६
arrow_upward
+४.१८%(+२.७२) 1D
अक्टोबर १५, १२:५६:१३ GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$ ६५.७१
High
R$ ६७.७६
Low
R$ ६५.७१
Mkt. cap
८२.४४ अरब
Avg. vol.
७१२.००
Volume
१.५० हजार
52-wk high
R$ ७३.१३
52-wk low
R$ ४९.९१
Shares outstanding
१०.११ करोड
No. of employees
१५ हजार
Open
R$ ६५.७१
High
R$ ६७.७६
Low
R$ ६५.७१
Mkt. cap
८२.४४ अरब
Avg. vol.
७१२.००
Volume
१.५० हजार
52-wk high
R$ ७३.१३
52-wk low
R$ ४९.९१
Shares outstanding
१०.११ करोड
No. of employees
१५ हजार
News stories
From web sources and news partners
Yahoo Finance
·
३ घण्टा पहिले
Q2 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
MarketBeat
·
६ घण्टा पहिले
2,188 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by B.A. Schrock Wealth Management Inc.
Simply Wall Street
·
८ घण्टा पहिले
Regeneron (REGN) Stock Looks Below Fair Value On Earnings
Trefis
·
२० घण्टा पहिले
What Could Send Regeneron Stock Higher?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees१५.३ हजार
Founded१९८८
HeadquartersTarrytown, न्यू योर्क, संयुक्त राज्य अमेरिका
Sector-
Websiteregeneron.com